Skip to main content
. Author manuscript; available in PMC: 2022 Oct 8.
Published in final edited form as: Br J Haematol. 2022 May 4;198(2):307–316. doi: 10.1111/bjh.18214

Fig 3.

Fig 3.

Kaplan–Meier survival estimates for the Castleman disease patients with a Certification and Access Subcommittee-approved diagnosis in A, the general Castleman disease cohort (n = 139) and B, the idiopathic multicentric Castleman disease cohort (n = 71). CI, Confidence interval; KM, Kaplan-Meier.